Market Overview

Global $16.7 Bn Clinical Microbiology Market, 2018-2025 - Market is Dominated by bioMerieux, Cepheid, Danaher and Bruker


Global $16.7 Bn Clinical Microbiology Market, 2018-2025 - Market is Dominated by bioMerieux, Cepheid, Danaher and Bruker

PR Newswire

DUBLIN, Aug 16, 2018 /PRNewswire/ --

The "Clinical Microbiology Market Size, Share & Trends Analysis Report By Product, By Application (Bloodstream, Respiratory, Gastrointestinal, Periodontal, STD, UTI), By Region, And Segment Forecasts, 2018 - 2025" report has been added to's offering.

Research and Markets Logo

The global clinical microbiology market size is expected to reach USD 16.7 billion by 2025

It is projected to expand at a CAGR of 6.7% over the forecast period. Clinical microbiology depends on technical and skilled workforce to process and interpret results of clinical specimens. Clinical staff have been complaining about poor Turnaround Time (TAT) of tests. However, with technological advancements, a number of laboratory instruments and equipment are being replaced with automated devices to minimize human error and dependency on skilled workforce.

In addition, automation has benefits such as reduced TAT and use of labor and lab space, thereby reducing overall cost associated with these tests. Manufacturers are focusing on introduction of automatic specimen processing, plate reading, and organism identification. GE Healthcare, PerkinElmer, and Thermo Fisher are some of the key players offering automated systems in the diagnostics industry.

Rising cases of hospital-acquired infections (HAI) is also fueling demand for clinical microbiology for diagnosis and monitoring. As high-income countries are stepping up their pursuit of countering hospital-acquired infections, middle- and low-income countries are recognizing the threat. Introduction of automated systems and innovative designs is expected to intensify market competition and change market dynamics over the forecast period.

The World Health Organization (WHO) is particularly active in countries such as Ethiopia, Burkina Faso, Nigeria, Algeria, and Senegal, where occurrence of HAIs ranged between 2.5% and 14.8%. This has led to increased demand for HAI diagnostics in these countries. Countries such as India, Sri Lanka, Pakistan, and Bhutan are also actively participating in HAI awareness programs. India and China are projected to be the main countries driving demand for HAI diagnostics instruments and tests in future.

Further key findings from the study suggest:

  • Owing to rapid adoption of technology and automation of work flow, laboratory instruments are expected to form the fastest growing segment over the forecast period
  • Reagents captured the largest revenue share in 2016 owing to repeat purchase of reagents
  • In 2015, North America dominated the global market. Continuous research on infectious disease treatment and subsequent grants from government healthcare agencies are contributing to development of a strong ecosystem in the region
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period owing to rising geriatric population in India, China, and Japan. This has resulted in high prevalence of re-emerging infectious diseases such as tuberculosis, cholera, and typhoid
  • The clinical microbiology market is presently dominated by a few key participants such as bioMerieux S.A.; Cepheid Inc.; Danaher Corporation; and Bruker Corporation
  • Other prominent players operating in the market include Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics; and Alere Inc.

Key Topics Covered:

Chapter 1 Research Methodology
1.1 Information procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Region Wise Market Calculation
1.4.1 Region Wise Market: Base Estimates
1.4.2 Global Market: CAGR Calculation
1.5 Region based segment share calculation
1.6 List of Secondary Sources

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Clinical Microbiology Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Rising Demand for Automation
3.2.2 Increasing Prevalence of Infectious and Chronic Diseases
3.3 Market Restraint Analysis
3.3.1 Lack of skilled professionals
3.4 Penetration & growth prospect mapping
3.5 Clinical Microbiology Market - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter's

Chapter 4 Clinical Microbiology Market: Product Estimates & Trend Analysis
4.1 Clinical Microbiology Market: Product Movement Analysis
4.2 Incubators
4.2.1 Incubators Market Revenue, 2014 - 2025 (USD Million)
4.2.2 Gram Stainers
4.2.3 Bacterial Colony Counters
4.2.4 Autoclave Sterilizers
4.2.5 Petri Dish Fillers
4.2.6 Automated Cell Culture Systems
4.3 Microbiology Analyzers
4.3.2 Molecular Diagnostic Instrument
4.3.3 Microscopes
4.3.4 Mass Spectrometers
4.4 Reagents

Chapter 5 Clinical Microbiology Market: Application Estimates & Trend Analysis
5.1 Respiratory Diseases
5.2 Bloodstream Infections
5.3 Gastrointestinal Diseases
5.4 Urinary Tract Infections
5.5 Sexually Transmitted Diseases
5.6 Periodontal Disease
5.7 Others

Chapter 6 Clinical Microbiology Market: Regional Estimates & Trend Analysis, by Products and Application

Chapter 7 Competitive Landscape

  • bioMerieux S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Bruker
  • Alere Inc.
  • Cepheid Inc.
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Cision View original content:

SOURCE Research and Markets

View Comments and Join the Discussion!